Rubicon Founders LLC purchased a new position in shares of Agilon Health, Inc. (NYSE:AGL - Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 105,341 shares of the company's stock, valued at approximately $11,290,448. Agilon Health comprises approximately 0.0% of Rubicon Founders LLC's investment portfolio, making the stock its 3rd largest holding. Rubicon Founders LLC owned 0.63% of Agilon Health at the end of the most recent quarter.
Other institutional investors and hedge funds have also made changes to their positions in the company. LPL Financial LLC increased its stake in shares of Agilon Health by 213.4% during the 4th quarter. LPL Financial LLC now owns 44,055 shares of the company's stock worth $30,000 after purchasing an additional 30,000 shares during the last quarter. CIBC Bancorp USA Inc. acquired a new position in shares of Agilon Health during the 3rd quarter worth $34,000. Merit Financial Group LLC acquired a new position in Agilon Health in the fourth quarter valued at approximately $35,000. Focus Partners Advisor Solutions LLC purchased a new position in Agilon Health in the fourth quarter worth $53,000. Finally, Alpine Global Management LLC purchased a new stake in Agilon Health in the fourth quarter worth approximately $84,000.
Analyst Ratings Changes
A number of equities analysts recently weighed in on AGL shares. Jefferies Financial Group upgraded shares of Agilon Health from a "hold" rating to a "buy" rating and upped their target price for the stock from $27.50 to $48.00 in a research report on Thursday, May 7th. TD Cowen reaffirmed a "hold" rating and issued a $55.00 price target (up from $17.00) on shares of Agilon Health in a report on Monday, May 11th. Barclays set a $111.00 price objective on Agilon Health and gave the stock an "equal weight" rating in a research report on Thursday, August 6th. Deutsche Bank Aktiengesellschaft upgraded shares of Agilon Health from a "hold" rating to a "buy" rating and raised their price target for the stock from $33.00 to $49.00 in a research report on Thursday, May 7th. Finally, Wells Fargo & Company reiterated an "overweight" rating and issued a $146.00 price objective (up from $141.00) on shares of Agilon Health in a research note on Tuesday, August 11th. Five analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of "Hold" and an average target price of $97.70.
Check Out Our Latest Analysis on AGL
Agilon Health Stock Performance
Shares of Agilon Health stock traded down $1.43 during trading hours on Friday, reaching $92.75. The company had a trading volume of 67,464 shares, compared to its average volume of 349,465. The firm has a market cap of $1.56 billion, a PE ratio of -6.50 and a beta of 3.01. Agilon Health, Inc. has a one year low of $7.48 and a one year high of $133.04. The business has a fifty day simple moving average of $104.53 and a 200 day simple moving average of $63.36. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.08 and a quick ratio of 1.08.
Agilon Health (NYSE:AGL - Get Free Report) last released its quarterly earnings data on Wednesday, August 5th. The company reported $1.04 EPS for the quarter, beating the consensus estimate of $0.14 by $0.90. Agilon Health had a negative return on equity of 119.38% and a negative net margin of 3.92%.The company had revenue of $1.49 billion for the quarter, compared to analysts' expectations of $1.45 billion. On average, analysts anticipate that Agilon Health, Inc. will post -2.33 earnings per share for the current fiscal year.
Agilon Health Company Profile
(
Free Report)
Agilon Health NYSE: AGL is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.
Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.
See Also
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Agilon Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Agilon Health wasn't on the list.
While Agilon Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
